TCTim Yannick Cras

Tim Yannick Cras

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tim Yannick Cras has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of American and European Guideline Recommendations for Diagnostic Workup and Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack

    by Maxim J.H.L. Mulder, Tim Y. Cras, James Shay, Diederik W.J. Dippel, James F. Burke

    Guidelines help to facilitate treatment decisions based on available evidence, and also to provide recommendations in areas of uncertainty. In this paper, we compare the recommendations for stroke workup and secondary prevention of ischemic stroke and transient ischemic attack of the American Heart Association (AHA)/American Stroke Association (ASA) with the European Stroke Organization (ESO) guidelines. The primary aim of this paper is to offer clinicians guidance by identifying areas where there is consensus and where consensus is lacking, in the absence or presence of high-level evidence. We compared AHA/ASA with the ESO guideline recommendations for 7 different topics related to diagnostic stroke workup and secondary prevention. We categorized the recommendations based on class and level of evidence to determine whether there were relevant differences in the ratings of evidence that the guidelines used for its recommendations. Finally, we summarized major topics of agreement and disagreement, while also prominent knowledge gaps were identified. In total, we found 63 ESO and 82 AHA/ASA recommendations, of which 38 were on the same subject. Most recommendations are largely similar, but not all are based on high-level evidence. For many recommendations, AHA/ASA and ESO assigned different levels of evidence. For the 10 recommendations with Level A evidence (high quality) in AHA/ASA, ESO only labeled 4 of these as high quality . There are many remaining issues with either no or insufficient evidence, and some topics that are not covered by both guidelines. Most ESO and AHA/ASA Guideline recommendations for stroke workup and secondary prevention were similar. However not all were based on high-level evidence and the appointed level of evidence often differed. Clinicians should not blindly follow all guideline recommendations; the accompanying level of evidence informs which recommendations are based on robust evidence. Topics with lower levels of evidence, or those with recommendations that disagree or are missing, may be an incentive for further clinical research.


  • Open Access

    Performance of a Diagnostic Model for the Presence of Unruptured Intracranial Aneurysms in the General Population

    by Vita M. Klieverik, Bob Roozenbeek, Tim Y. Cras, Meike W. Vernooij, Mirjam I. Geerlings, Daniel Bos, Ynte M. Ruigrok

    Introduction: The prevalence of unruptured intracranial aneurysms (UIAs) in the general population is 3%. Aneurysmal subarachnoid hemorrhage can be prevented by screening for UIAs followed by monitoring and, if needed, preventive neurosurgical or endovascular treatment of identified UIAs. Therefore, we developed a diagnostic model for the presence of UIAs in the general population to help identify persons at high risk of having UIAs. Methods: Between 2005 and 2015, participants from the population-based Rotterdam Study underwent brain magnetic resonance imaging at 1.5 T, on which the presence of incidental UIAs was evaluated. We developed a multivariable logistic regression model using candidate diagnostic markers that were selected based on the literature, including sex, age, hypertension, smoking, hypercholesterolemia, diabetes, alcohol, and their interactions. We corrected for overfitting using bootstrapping. Model performance was assessed with discrimination, calibration, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Results: 5,835 persons were included (55.0% women, mean age 64.9 ± 10.9 years) with a 2.2% UIA prevalence. Sex, age, hypertension, smoking, diabetes, and interactions of sex with age, hypertension, and smoking were independent diagnostic markers. The resulting model had a c-statistic of 0.65 (95% confidence interval [CI]: 0.60–0.68) and 56% sensitivity, 52% specificity, 98% PPV, and 3% NPV for UIA presence at a cutoff value of 4%. Because of interactions with sex, additional models for men and women separately were developed. The model for men had a c-statistic of 0.70 (95% CI: 0.62–0.78) with age, hypertension, and smoking as diagnostic markers and comparable additional performance values as for the full model. The model for women had a c-statistic of 0.58 (95% CI: 0.52–0.63) with smoking as the only diagnostic marker. Conclusion: Our diagnostic model had insufficient performance to help identify persons at high risk of having UIAs in the general population. Rather, it provides insight in risk factors contributing to UIA risk and shows that these may be in part sex-specific.


  • Open Access

    Performance of a diagnostic model for the presence of unruptured intracranial aneurysms in the general population

    by Vita M. Klieverik, Bob Roozenbeek, Tim Y. Cras, Meike W. Vernooij, Mirjam I. Geerlings, Daniel Bos, Ynte M. Ruigrok

    Background The prevalence of unruptured intracranial aneurysms (UIAs) in the general population is 3%. Aneurysmal subarachnoid hemorrhage can be prevented by screening for UIAs followed by preventive treatment of identified UIAs. We developed a diagnostic model for presence of UIAs in the general population to help identify persons at high risk of having UIAs. Methods Between 2005-2015, middle aged and elderly participants from the population-based Rotterdam Study underwent brain magnetic resonance imaging at 1.5 Tesla, on which presence of incidental UIAs was evaluated. A multivariable logistic regression model with diagnostic markers sex, age, hypertension, smoking, hypercholesterolemia, diabetes, and alcohol, and their interactions, was developed. We corrected for overfitting using bootstrapping. Model performance was assessed with discrimination, calibration, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Results 5835 persons were included (55.0% women, mean age 64.9±10.9 years) with a 2.2% UIA prevalence. Sex, age, hypertension, smoking, diabetes, and interactions of sex with age, hypertension, and smoking were independent diagnostic markers. The resulting model had a c-statistic of 0.65 (95% confidence interval [CI] 0.60–0.68) and 56% sensitivity, 52% specificity, 98% PPV, and 3% NPV for UIA presence at a cut-off value of 4% prevalence. Because of interactions with sex, additional models for men and women separately were developed. The model for men had a c-statistic of 0.70 (95%CI 0.62–0.78) with age, hypertension, and smoking as diagnostic markers and comparable additional performance values as for the full model. The model for women had a c-statistic of 0.58 (95%CI 0.52–0.63) with smoking as the only diagnostic marker. Conclusion Our diagnostic model had insufficient performance to help identify persons at high risk of having UIAs in the general population. Rather, it provides insight in risk factors contributing to UIA risk and shows that these may be in part sex-specific.

  • Surveillance of Unruptured Intracranial Aneurysms

    by Tim Yannick Cras, Myriam M.G. Hunink, Ruben Dammers, Adriaan C.G.M. van Es, Victor Volovici, James F Burke, Femke C.C. Kremers, Diederik W.J. Dippel, Bob Roozenbeek

  • Surveillance of Unruptured Intracranial Aneurysms

    by Tim Yannick Cras, Myriam M.G. Hunink, Ruben Dammers, Adriaan C.G.M. van Es, Victor Volovici, James F. Burke, Femke C.C. Kremers, Diederik W.J. Dippel, Bob Roozenbeek

    Background and Objectives: No consensus exists on adequate surveillance of conservatively managed unruptured intracranial aneurysms (UIAs). We aimed to determine optimal MRI surveillance strategies for growth of UIAs using cost-effectiveness analysis. A secondary aim was to develop a clinical tool for personalizing UIA surveillance. Methods: We designed a microsimulation model from a health care perspective simulating 100,000 55-year old women to estimate costs and quality-adjusted life years (QALYs) over a lifetime horizon in the US, UK, and the Netherlands, using literature-derived model parameters. Country-specific costs and willingness-to-pay thresholds ($100,000/QALY for the US, £30,000/QALY for the UK, and €80,000/QALY for the Netherlands) were used. Lifetime costs and QALYs were annually discounted at 3% for the US, 3.5% for the UK, or 4% (costs) and 1.5% (QALYs) for the Netherlands. Strategies were: no follow-up surveillance, follow-up with MRI in the 1st and 5th year after UIA discovery, every 5 years, every 2 years, or annually, or immediate intervention (i.e., clipping or coiling). Using the microsimulation model, we developed a tool for personalizing UIA surveillance for men and women, with different ages and varying aneurysm characteristics. Uncertainty in the input parameters was modeled with probabilistic sensitivity analysis. Results: Among 55-year old women, 2,222 individuals in the US, 1,910 in the UK, and 2,040 in the Netherlands needed to undergo an annual MRI scan to prevent one case of subarachnoid hemorrhage per year. No surveillance MRI was most cost-effective in the US (in 47% of the simulations) and UK (in 54% of simulations), whereas annual MRI was most cost-effective in the Netherlands (in 53% of simulations). In the US and UK, annual surveillance or surveillance in the 1st and 5th year after discovery was cost-effective in patients <60 years and at increased risk of aneurysm growth. The optimal, personalized, surveillance strategies were summarized in a look-up table for use in clinical practice. Conclusion: Generally, US and UK physicians should refrain from assigning patients, particularly older patients and those with few risk factors for aneurysm growth or rupture, to frequent MRI surveillance. In the Netherlands, annual follow-up is generally most cost-effective.


  • Open Access

    Determinants of the Presence and Size of Intracranial Aneurysms in the General Population

    by Tim Y. Cras, Daniel Bos, M. Arfan Ikram, Mervyn D.I. Vergouwen, Diederik W.J. Dippel, Trudy Voortman, Hieab H.H. Adams, Meike W. Vernooij, Bob Roozenbeek

    Background and Purpose: The prevalence of unruptured intracranial aneurysms (UIAs) in the adult population is ≈3%. Rupture of an intracranial aneurysm can have devastating consequences, which emphasizes the importance of identification of potentially modifiable determinants for the presence and size of UIAs. Our aim was to study the association of a broad spectrum of potential determinants with the presence and size of UIAs in a general adult population. Methods: Between 2005 and 2015, 5841 participants from the population-based Rotterdam Study (mean age, 64.4 years, 45.0% male) underwent brain magnetic resonance imaging (1.5T). These scans were evaluated for the presence of incidental UIAs. We determined number and volume of the UIAs. Using logistic and linear regression models, we assessed the association of cardiovascular, lifestyle and emerging inflammatory and hormonal determinants with the presence and volume of UIAs. Results: In 134 (2.3%) participants, ≥1 UIAs were detected (149 UIAs in total), with a median volume of 61.1 mm 3 (interquartile range, 33.2–134.0). In multivariable models, female sex (odds ratio, 1.92 [95% CI, 1.33–2.84]), hypertension (odds ratio, 1.73 [95% CI, 1.13–2.68]), and current smoking (odds ratio, 3.75 [95% CI, 2.27–6.33]) were associated with the presence of UIAs. We found no association of alcohol use, physical activity, or diet quality with UIA presence. Finally, we found white blood cell count to relate to larger aneurysm volume (difference in volume of 33.6 mm 3 per 10 9 /L increase in white blood cell [95% CI, 3.92–63.5]). Conclusions: In this population-based study, female sex, hypertension, and smoking, but no other lifestyle determinants, were associated with the presence of UIAs. White blood cell count is associated with size of UIAs. Preventive strategies should focus on treating hypertension and promoting cessation of smoking.